Literature DB >> 25701027

Inhibition of metastasis and growth of breast cancer by pH-sensitive poly (β-amino ester) nanoparticles co-delivering two siRNA and paclitaxel.

Shan Tang1, Qi Yin2, Jinghan Su1, Huiping Sun1, Qingshuo Meng1, Yi Chen1, Lingli Chen1, Yongzhuo Huang1, Wangwen Gu1, Minghua Xu1, Haijun Yu1, Zhiwen Zhang1, Yaping Li3.   

Abstract

Breast cancer is the most vicious killer for women's health, while metastasis is the main culprit, which leads to failure of treatment by increasing relapse rate. In this work, a new complexes nanoparticles loading two siRNA (Snail siRNA (siSna) and Twist siRNA (siTwi)) and paclitaxel (PTX) were designed and constructed using two new amphiphilic polymer, polyethyleneimine-block-poly[(1,4-butanediol)-diacrylate-β-5-hydroxyamylamine] (PEI-PDHA) and polyethylene glycol-block-poly[(1,4-butanediol)-diacrylate-β-5-hydroxyamylamine] (PEG-PDHA) by self-assembly. The experimental results showed that in the 4T1 tumor-bearing mice models, PEI-PDHA/PEG-PDHA/PTX/siSna/siTwi) complex nanoparticles (PPSTs) raised the accumulation and retention of both PTX and siRNA in tumor after administrated intravenously, resulted in the strong inhibition of the tumor growth and metastasis simultaneously. It was found that co-delivery of siSna and siTwi had more significant anti-metastasis effect than delivering a single siRNA, as a result of simultaneously inhibiting the motility of cancer cells and degradation of ECM. Therefore, PPSTs could be a promising co-delivery vector for effective therapy of metastatic breast cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Co-delivery; Metastasis; Paclitaxel; Poly (β-amino ester); RNA interference; pH-sensitive

Mesh:

Substances:

Year:  2015        PMID: 25701027     DOI: 10.1016/j.biomaterials.2015.01.049

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  27 in total

Review 1.  siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion.

Authors:  Worapol Ngamcherdtrakul; Wassana Yantasee
Journal:  Transl Res       Date:  2019-08-19       Impact factor: 7.012

Review 2.  Organic nanoparticle systems for spatiotemporal control of multimodal chemotherapy.

Authors:  Fanfei Meng; Ning Han; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2016-08-08       Impact factor: 6.648

Review 3.  Cancer nanomedicine: progress, challenges and opportunities.

Authors:  Jinjun Shi; Philip W Kantoff; Richard Wooster; Omid C Farokhzad
Journal:  Nat Rev Cancer       Date:  2016-11-11       Impact factor: 60.716

Review 4.  The potential of micelleplexes as a therapeutic strategy for osteosarcoma disease.

Authors:  Catarina Melim; Ivana Jarak; Francisco Veiga; Ana Figueiras
Journal:  3 Biotech       Date:  2020-03-02       Impact factor: 2.406

Review 5.  Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Authors:  Yunchun Zhao; Xiaoling Zheng; Yongquan Zheng; Yue Chen; Weidong Fei; Fengmei Wang; Caihong Zheng
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

6.  Vitamin E succinate-conjugated F68 micelles for mitoxantrone delivery in enhancing anticancer activity.

Authors:  Yuling Liu; Yingqi Xu; Minghui Wu; Lijiao Fan; Chengwei He; Jian-Bo Wan; Peng Li; Meiwan Chen; Hui Li
Journal:  Int J Nanomedicine       Date:  2016-07-12

7.  Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.

Authors:  Ping Sun; Wei Huang; Mingji Jin; Qiming Wang; Bo Fan; Lin Kang; Zhonggao Gao
Journal:  Int J Nanomedicine       Date:  2016-09-27

8.  A pH-Responsive Host-guest Nanosystem Loading Succinobucol Suppresses Lung Metastasis of Breast Cancer.

Authors:  Zhaoling Dan; Haiqiang Cao; Xinyu He; Zhiwen Zhang; Lili Zou; Lijuan Zeng; Yan Xu; Qi Yin; Minghua Xu; Dafang Zhong; Haijun Yu; Qi Shen; Pengcheng Zhang; Yaping Li
Journal:  Theranostics       Date:  2016-01-25       Impact factor: 11.556

Review 9.  Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.

Authors:  Janel Kydd; Rahul Jadia; Praveena Velpurisiva; Aniket Gad; Shailee Paliwal; Prakash Rai
Journal:  Pharmaceutics       Date:  2017-10-14       Impact factor: 6.321

10.  Effect of Combined Treatment Using Wilfortrine and Paclitaxel in Liver Cancer and Related Mechanism.

Authors:  Shuzhen Li; Lei Zheng
Journal:  Med Sci Monit       Date:  2016-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.